Tech Company Financing Transactions
Pear Therapeutics Funding Round
Pear Therapeutics, based in Boston, secured funding from 5AM Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/20/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
5AM Ventures (Lead Investor) (Andrew Schwab)
Proceeds Purpose
The investment will allow Pear to build a portfolio of eFormulations.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
200 State St.
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Undisclosed
Website
Email Address
Overview
Pear Therapeutics' patented eFormulation approach combines mobile health apps with supplements, medical foods, and pharmaceuticals, to create more efficacious treatment solutions. eFormulations are simple to use. A software access code on the product packaging provides access to Pear's health apps.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Corey McCann
Chief Medical Officer
Yuri Maricich
Chief Operating Officer
Christopher Guiffre
Vice President
Catherine Cushenberry
Vice President
Mark Deeg
Vice President
Michael Pace
VP - Bus. Development
Julia Strandberg
VP - Bus. Development
Alex Waldron
VP - Engineering
Gordon Kass
VP - General Counsel
Ronan O'Brien
VP - Human Resources
Kathy Jeffery
VP - Marketing
Kirsten Carlson
VP - Product Management
Kathleen Bauman
VP - Product Management
Erin Brenner
VP - Regulatory Affairs
Steve Sherman
VP - Sales
Brian Prunier
Browse more venture capital transactions:
Prev: 3/20/2015: ezCater venture capital transaction
Next: 3/20/2015: StratoScientific venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs